Reaktionsgleichung
[CH3:1][C:2]1[CH:7]=[CH:6][C:5]([CH:8]([NH:17][C:18]([CH2:20][C:21]2[CH:30]=[CH:29][C:28]3[C:23](=[CH:24][CH:25]=[CH:26][CH:27]=3)[N:22]=2)=[O:19])[CH2:9][CH2:10][N:11]2[CH2:16][CH2:15][CH2:14][CH2:13][CH2:12]2)=[CH:4][CH:3]=1.O.O.[C:33]([OH:38])(=[O:37])[C:34]([OH:36])=[O:35]>>[C:33]([OH:38])(=[O:37])[C:34]([OH:36])=[O:35].[CH3:1][C:2]1[CH:3]=[CH:4][C:5]([CH:8]([NH:17][C:18]([CH2:20][C:21]2[CH:30]=[CH:29][C:28]3[C:23](=[CH:24][CH:25]=[CH:26][CH:27]=3)[N:22]=2)=[O:19])[CH2:9][CH2:10][N:11]2[CH2:12][CH2:13][CH2:14][CH2:15][CH2:16]2)=[CH:6][CH:7]=1Komponenten
3
Versuchsvorschrift
The procedure of Example 7 was repeated using 917 mg (2.36 mmol.) of N-[1-(4-methylphenyl)-3-piperidinopropyl]quinaldinamide and 298 mg (2.36 mmol.) of oxalic acid dihydrate, to obtain 901 mg (yield: 80%) of the subject compound as a whilte crystalline product upon recrystallization from 8 ml of ethanol.
Quellen und Nachweise
- ORD-Eintrag
- ord-d189332df8ad49bc8a8152b0d3067aa0
- Quelldatensatz
- uspto-grants-1988_08
- Patentnummer
- US04764617
Verknüpfte Notizen
Wird geladen…